<p>LOXL1-AS1 Contributes to Non-Small Cell Lung Cancer Progression by Regulating miR-3128/RHOXF2 Axis</p>-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

LOXL1-AS1 Contributes to Non-Small Cell Lung Cancer Progression by Regulating miR-3128/RHOXF2 Axis

Published:2020-06 Issue: Volume:Volume 13 Page:6063-6071
ISSN:1178-6930
Container-title:OncoTargets and Therapy
language:en
Short-container-title:OTT

Author:

Zhao Limin,Zhang Xuefei,Guo Huannan,Liu Mingyang,Wang Liming

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Oncology

Reference28 articles.

1. Significance of Primary Tumor Location and Histology for Brain Metastasis Development and Peritumoral Brain Edema in Lung Cancer

2. Lung cancer: New surgical approaches

3. SEOM clinical guidelines for the treatment of non-small cell lung cancer (2018)

4. Current Surgical Management of Gastric Carcinoma: Global Standards and Japanese Modifications

5. The clinical value of lung imaging fluorescence endoscopy for detecting synchronous lung cancer

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Oxaliplatin-induced upregulation of exosomal miR-424-3p derived from human bone marrow mesenchymal stem cells attenuates progression of gastric cancer cells;Scientific Reports;2024-08-01

2. H3K27ac-induced RHOXF2 activates Wnt2/β-catenin pathway by binding to HOXC13 to aggravate the malignant progression of triple negative breast cancer;Cellular Signalling;2024-08

3. A comprehensive review on lncRNA LOXL1-AS1: molecular mechanistic pathways of lncRNA LOXL1-AS1 in tumorigenicity of cancer cells;Frontiers in Oncology;2024-07-29

4. Involvement of long non-coding RNA LOXL1-AS1 in the tumourigenesis and development of malignant tumours: a narrative review;Translational Cancer Research;2024-06

5. Long non-coding RNA LOXL1-AS1: a potential biomarker and therapeutic target in human malignant tumors;Clinical and Experimental Medicine;2024-05-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3